Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

WW International, Inc. - Common Stock (NQ: WW )

0.8101 -0.0149 (-1.81%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about WW International, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Specialized Consumer Services Stocks Q3 Results: Benchmarking WeightWatchers (NASDAQ:WW)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the specialized consumer services industry, including WeightWatchers (NASDAQ:WW) and its peers. 
Via StockStory
10 Consumer Discretionary Stocks Whale Activity In Today's Session
Via Benzinga
WeightWatchers Unveils Next-Gen Program With AI-Powered App Features
With access to Registered Dietitians, 150+ New ZeroPoint® Foods and smarter tracking features, the new program delivers a cutting-edge, flexible approach to holistic weight management 
From WW International Inc.
Via GlobeNewswire
WW Stock Drops On Weak Q2 Results: Details
WW International shares are sinking Thursday after the company posted worse-than-expected second-quarter results. Here's a look at the details: 
Via Benzinga
Three Reasons to Avoid WW and One Stock to Buy Instead
WeightWatchers’s stock price has taken a beating over the past six months, shedding 40.1% of its value and falling to $1.03 per share. This might have investors contemplating their next move. 
Via StockStory
WW International's Slimmed-Down Profits: Cost Cuts Help, But Subscriber Losses Weigh On Q3 Results
WW International reported mixed Q3 2024 results with decline in revenues and subscribers. Cost reductions driving improved profitability. 
Via Benzinga
WeightWatchers (NASDAQ:WW) Posts Q3 Sales In Line With Estimates
Personal wellness company WeightWatchers (NASDAQ:WW) met Wall Street’s revenue expectations in Q3 CY2024, but sales fell 10.2% year on year to $192.9 million. On the other hand, the company’s full-year... 
Via StockStory
WeightWatchers (WW) To Report Earnings Tomorrow: Here Is What To Expect
Personal wellness company WeightWatchers (NASDAQ:WW) will be announcing earnings results tomorrow before market open. Here’s what to look for. 
Via StockStory
Bret Taylor's AI Startup Sierra Hits $4.5B Valuation Just A Year After Launch: OpenAI Chair's Latest Venture Towers Over These Century-Old Brands
Sierra, the AI startup co-founded by former Salesforce co-CEO Bret Taylor, reached a valuation of $4.5 billion after raising $175 million in a recent funding round, positioning it as a leading AI... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Latest on PepsiCo
For investors who are after steady, mature companies, beverage companies might be a good place to start. But not all of them bring the same returns to the table. 
Via The Motley Fool
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Leaders in The News: FuelCell Energy, WeightWatchers, NUBURU, New World Solutions
Latest Advances in Blue Lasers, Weight Loss Treatment, Clean Energy and Digital Transformation of $31 Billion Watch Market 
Via News Direct
What's Going With WeightWatchers Stock On Wednesday?
WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while grappling with insurance denials and FDA criticism over drug access. 
Via Benzinga
Exposures Product Safety
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them. 
Via InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
GLP-1s are a weight-loss breakthrough, but these three stocks to sell have a lot to lose from their rapid rise in popularity. 
Via InvestorPlace
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Via Benzinga
Can Weight Loss Companies Fuel Gains In Your Stock Portfolio?
Analysts predict the weight loss drug market could reach $100 billion by the end of the decade, with millions of patients potentially using these medications. However, challenges remain. 
Via Talk Markets
WW Stock Earnings: WW International Beats EPS, Beats Revenue for Q1 2024
WW stock results show that WW International beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
7 Penny Stocks With the Potential to Make You an Overnight Millionaire
Discover seven penny stocks poised for massive gains. These companies offer significant value and potentially life-changing returns. 
Via InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Consumer Stocks.
While some retail companies are still thriving, investors would be smart to steer clear of these consumer stocks to avoid. 
Via InvestorPlace
WeightWatchers Hosts ‘Making The Shift: A New Way to Think About Weight,’ A Live Virtual Event with Oprah Winfrey on Thursday, May 9
Special guests include Rebel Wilson, Katie Sturino, Amber Riley, Marisa Meltzer, Jamie Kern Lima, Tressie McMillan Cottom, and leading medical and science experts Dr. Rachel Goldman and Dr. Ania... 
From WW International Inc.
Via GlobeNewswire
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on... 
Via Benzinga
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session
Via Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.